|
|
||||||||
Animal: RNA Viruses |
Divisions of Clinical Virology, F68, and Biomedical Laboratory Technology1 and Division of Infectious Diseases, Department of Medicine2, Karolinska Institute, Huddinge University Hospital, S-141 86 Huddinge, Sweden
Department of Vaccinology, University of Ghent, Ghent, Belgium3
Department of Hepatology, Fundacion Jimenez Diaz, Madrid, Spain4
Department of Biochemistry, Virginia Commonwealth University, Richmond, VA, USA5
Vaccine Research Institute of San Diego, San Diego, CA, USA6
Author for correspondence: Matti Sällberg. Fax +46 8 5858 79 33. e-mail misg{at}labd01.hs.sll.se
The non-structural 3 (NS3) protein is one of the most conserved proteins of hepatitis C virus, and T helper 1 (Th1)-like responses to NS3 in humans correlate with clearance of infection. Several studies have proposed that DNA-based immunizations are highly immunogenic and prime Th1-like responses, although few head-to-head comparisons with exogenous protein immunizations have been described. A full-length NS3/NS4A gene was cloned in eukaryotic vectors with expression directed to different subcellular compartments. Inbred mice were immunized twice in regenerating tibialis anterior (TA) muscles with either plasmid DNA or recombinant NS3 (rNS3). After two 100 µg DNA immunizations, specific antibody titres of up to 12960 were detected at week 5, dominated by IgG2a and IgG2b. NS3-specific CD4+ T cell responses in DNA-immunized mice peaked at day 13, as measured by proliferation and IL-2 and IFN-
production. Mice immunized with 110 µg rNS3 without adjuvant developed antibody titres comparable to those of the DNA-immunized mice, but dominated instead by IgG1. CD4+ T cell responses in these mice showed peaks of IL-2 response at day 3 and IL-6 and IFN-
responses at day 6. With adjuvant, rNS3 was around 10-fold more immunogenic with respect to speed and magnitude of the immune responses. Thus, immunization with rNS3 in adjuvant is superior to DNA immunization with respect to kinetics and quantity in priming specific antibodies and CD4+ T cells. However, as a DNA immunogen, NS3 elicits stronger Th1-like immune responses, whereas rNS3 primes a mixed Th1/Th2-like response regardless of the route, dose or adjuvant.
This article has been cited by other articles:
![]() |
G Ahlen, E Derk, M Weiland, J Jiao, N Rahbin, S Aleman, D L Peterson, K Pokrovskaja, D Grander, L Frelin, et al. Cleavage of the IPS-1/Cardif/MAVS/VISA does not inhibit T cell-mediated elimination of hepatitis C virus non-structural 3/4A-expressing hepatocytes Gut, April 1, 2009; 58(4): 560 - 569. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ahlen, J. Soderholm, T. Tjelle, R. Kjeken, L. Frelin, U. Hoglund, P. Blomberg, M. Fons, I. Mathiesen, and M. Sallberg In Vivo Electroporation Enhances the Immunogenicity of Hepatitis C Virus Nonstructural 3/4A DNA by Increased Local DNA Uptake, Protein Expression, Inflammation, and Infiltration of CD3+ T Cells J. Immunol., October 1, 2007; 179(7): 4741 - 4753. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Soderholm, G Ahlen, A Kaul, L Frelin, M Alheim, C Barnfield, P Liljestrom, O Weiland, D R Milich, R Bartenschlager, et al. Relation between viral fitness and immune escape within the hepatitis C virus protease Gut, February 1, 2006; 55(2): 266 - 274. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Karayiannis, J. Main, and H. C. Thomas Hepatitis vaccines Br. Med. Bull., August 31, 2004; 70(1): 29 - 49. [Full Text] [PDF] |
||||
![]() |
H. Yu, L. A. Babiuk, and S. van Drunen Littel-van den Hurk Priming with CpG-enriched plasmid and boosting with protein formulated with CpG oligodeoxynucleotides and Quil A induces strong cellular and humoral immune responses to hepatitis C virus NS3 J. Gen. Virol., June 1, 2004; 85(6): 1533 - 1543. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Jiao, R. Y.-H. Wang, Q. Qiu, H. J. Alter, and J. W.-K. Shih Enhanced hepatitis C virus NS3 specific Th1 immune responses induced by co-delivery of protein antigen and CpG with cationic liposomes J. Gen. Virol., June 1, 2004; 85(6): 1545 - 1553. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Simon, K. A. Cornell, T. R. Clark, S. Chou, H. R. Rosen, and R. A. Barry DNA Vaccination Protects Mice against Challenge with Listeria monocytogenes Expressing the Hepatitis C Virus NS3 Protein Infect. Immun., November 1, 2003; 71(11): 6372 - 6380. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Lazdina, M. Alheim, J. Nystrom, C. Hultgren, G. Borisova, I. Sominskaya, P. Pumpens, D. L. Peterson, D. R. Milich, and M. Sallberg Priming of cytotoxic T cell responses to exogenous hepatitis B virus core antigen is B cell dependent J. Gen. Virol., January 1, 2003; 84(1): 139 - 146. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |